✦ LIBER ✦

1839 EVALUATING THE ASSOCIATION AMONG THE PHARMACOKINETICS OF SUNITINIB, ITS ADVERSE EVENTS AND THE TREATMENT OUTCOMES IN ADVANCED RENAL CELL CARCINOMA

✍ Scribed by Tsuchiya, Norihiko; Fujiyama, Nobuhiro; Narita, Shintaro; Inoue, Takamitsu; Numakura, Kazuyuki; Akihama, Susumu; Saito, Mitsuru; Satoh, Shigeru; Miura, Masatomo; Habuchi, Tomonori

Book ID: 123121999
Publisher: Lippincott Williams and Wilkins
Year: 2013
Tongue: English
Weight: 119 KB
Volume: 189
Category: Article
ISSN: 0022-5347
DOI: 10.1016/j.juro.2013.02.2222

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

1100 Association of pharmacokinetics of

1100 Association of pharmacokinetics of sunitinib with treatment outcome and adverse events in advanced renal cell carcinoma patients

✍ Tsuchiya, N.; Fujiyama, N.; Narita, S.; Inoue, T.; Numakura, K.; Akihama, S.; Sa 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 152 KB

1136 Pharmacokinetics in the early perio

1136 Pharmacokinetics in the early period after sunitinib treatment predict adverse events and clinical outcome of patients with advanced renal cell carcinoma

✍ Takayama, K.; Tsuchiya, N.; Narita, S.; Inoue, T.; Saito, M.; Numakura, K.; Tsur 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 986 KB

Management of sunitinib adverse events i

Management of sunitinib adverse events in renal cell carcinoma patients: The Asian experience

✍ Aiping ZHOU 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB

Management of adverse events associated

Management of adverse events associated with the use of everolimus in patients with advanced renal cell carcinoma

✍ Camillo Porta; Susanne Osanto; Alain Ravaud; Miguel-Angel Climent; Ulka Vaishamp 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 606 KB

Prospective study assessing hypoxia-rela

Prospective study assessing hypoxia-related proteins as markers for the outcome of treatment with sunitinib in advanced clear-cell renal cell carcinoma

✍ Garcia-Donas, J.; Leandro-Garcia, L. J.; Gonzalez del Alba, A.; Morente, M.; Ale 📂 Article 📅 2013 🏛 Oxford University Press 🌐 English ⚖ 193 KB

7141 Costs of adverse events management

7141 Costs of adverse events management associated to the treatment of first-line metastatic renal cell carcinoma with bevacizumab + interferon alpha-2a compared with sunitinib in Spain

✍ Puente, J.; Calderero, V.; García-Muro, X.; Trigo, J.M.; Castro, A.J.; Martin-Es 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 50 KB